Program #905 • Available July 22, 2013
Certified for AMA PRA Category 1 Credit™ and continuing education for nurses through July 22, 2016

Cognitive Impairment in Multiple Sclerosis:
New Research on Diagnosis and Management

Faculty
Kottil Rammohan, MD, Chair
Professor of Neurology
Director, MS Center
University of Miami Miller School of Medicine
Miami, Florida

Frederick W. Foley, PhD
Professor of Psychology
Ferkauf Graduate School of Psychology
Yeshiva University
Bronx, New York
Director of Neuropsychology and Psychosocial Research
Multiple Sclerosis Center
Holy Name Medical Center
Teaneck, New Jersey

Lauren Krupp, MD
Professor of Neurology, Psychology and Pediatrics
Director, Lourie Center for Pediatric MS
Co-Director, MS Comprehensive Care Center
Director, Neuropsychology Research
Stony Brook Medicine
Stony Brook, New York

Bonnie E. Levin, PhD
Alexandria and Bernard Schoninger Professor of Neurology
Department of Neurology
University of Miami Miller School of Medicine
Miami, Florida

Program Description

Cognitive changes can be expected in more than half of multiple sclerosis (MS) patients and include deficits in processing speed, working memory, episodic memory, spatial processing, verbal fluency and executive function. These impairments can be highly disruptive to personal independence, social interaction, and quality of life. Join Dr. Kottil Rammohan and a distinguished panel of experts for an expert review on the assessment of MS-related cognitive impairment, the role of neuroimaging in diagnosis and monitoring, and the potential impact of disease modifying therapies on improving cognition. This activity is based on the proceedings from a live interactive workshop held with MS clinical team members.

(60 minutes)

This enduring material is co-provided by the Consortium of Multiple Sclerosis Centers, Nurse Practitioner Alternatives, and the Foundation for Improving Patient Outcomes.

It is supported by an educational grant from Novartis Pharmaceuticals

Method of Participation and Evaluation

To participate in this CME/CNE activity, please read the following information and click "Launch Program" at the bottom of this page. Complete the online evaluation at the conclusion of the activity. You may print your certificate immediately after completion of the evaluation. Please note: To view this program you need a computer with an Internet browser and audio and video capabilities.

Credit Information

Up to 1.0 AMA PRA Category 1 Credit

Up to 1.0 CNE Contact Hour

This CME/CNE activity is designed for multiple sclerosis treatment team members including: MS specialists, neurologists, neuroradiologists, physician assistants, nurse practitioners, other MS care team members, and other healthcare professionals who manage MS patients.

Learning Objectives

After taking part in this CME activity, the learners will be able to:

  • Incorporate the assessment of cognitive and psychological dysfunction into clinical assessment
  • Utilize current guidelines for the use of MRI to correlate clinical findings with neuroimaging
  • Incorporate research findings on the potential efficacy of disease modifications into treatment decisions in those patients experiencing both active disease and cognitive and emotional dysfunction

Faculty and Planner Disclosures::

Lauren Krupp, MD is in receipt of intellectual property rights/patent holder from Johnson and Johnson and Teva Neurosciences, and has served as a consultant to Biogen Idec, EMD Serono, Inc., Genentech Inc., and Novartis Pharmaceuticals. She has received research support from Celgene Corporation, Novartis Pharmaceuticals and Teva Neurosciences. Bonnie E. Levin, PhD reports no financial relationships with commercial interests.

Kottil Rammohan, MD*, has served as a consultant to Biogen Idec, EMD Serono, Inc., Genentech, Inc., Genzyme Corporation, and Teva Pharmaceuticals Industries Ltd. He has received research support from Acorda Therapeutics Inc., EMD Serono, Inc., Genentech, Inc, Immune Tolerance Network, National Institutes of Health and Teva Pharmaceuticals Industries Ltd., and has received support from Acorda Therapeutics Inc., Biogen Idec., and Genzyme Corporation.

June Halper, MSN, APN-C* has served as a consultant and is a speaker for non-CME programs for Acorda Therapeutics Inc.

Laurie Scudder, DNP, NP* has served as nurse planner and peer reviewer for this activity and reports no financial relationships with commercial interest.

The staff of the Foundation for Improving Patient Outcomes reports no financial relationships with commercial interests.

*Planning committee member.

CME Information:

This enduring material has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and the Foundation for Improving Patient Outcomes (FFIPO).

CMSC is accredited by the ACCME to provide continuing medical education for physicians.

CNE Information:

This activity is jointly sponsored by Consortium of Multiple Sclerosis, Nurse Practitioner Alternatives and the Foundation for Improving Patient Outcomes.

NPA is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission (ANCC) on Accreditation.

Accreditation does not imply endorsement by CMSC, NPA, FFIPO or ANCC of recommendations or any commercial products displayed or discussed in conjunction with the educational activity.

Credit Designation Statement

CMSC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material activity is awarded 1 contact hour of continuing education credit for nurses and advanced practice nurses.


Launch Program
Web Evaluation
Print Evaluation
«
Please login or create an account to access course. For more information, click here.